Agenus Inc.

NASDAQ: AGENHealthcare / Biotechnology / USA
3.01+0.0100+0.33%Vol 1 430 4041Y Perf 23.66%
Jun 24th, 2019 16:00
BID3.00 ASK3.01
Open3.01 Previous Close3.00
Pre-Market2.99 After-Trading3.01
 -0.01 -0.33%  -0.03 -0.99%
Target Price
5.50 
Analyst Rating
Strong Buy 1.00
Potencial %
82.72 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
★+     42.22
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)404 
Earnings Rating
Price Range Ratio 52wk %
62.82 
Earnings Date
8th Aug 2019

Today's Price Range

2.993.06

52wk Range

1.543.88

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Month
5.24%
3 Months
6.36%
6 Months
35.59%
1 Year
23.66%
3 Years
-23.02%
5 Years
-12.24%

Name / TickerPriceChg.Chg.%
AGEN3.010.01000.33
AAPL198.58-0.2000-0.10
GOOG1 115.52-6.3600-0.57
MSFT137.780.81000.59
XOM76.95-0.7400-0.95
WFC46.27-0.6200-1.32
JNJ143.060.97000.68
FB192.601.46000.76
GE10.28-0.2000-1.91
JPM108.66-0.7800-0.71
Earnings HistoryEstimateReportedSurprise %
Q01 2019-0.300.12140.00
Q04 2018-0.28-0.40-42.86
Q03 2018-0.25-0.29-16.00
Q02 2018-0.38-0.2436.84
Q01 2018-0.28-0.42-50.00
Q04 2017-0.28-0.35-25.00
Q03 2017-0.37-0.370.00
Q02 2017-0.36-0.3211.11
Earnings Per EndEstimateRevision %Trend
6/2019 QR-0.33-6.45Negative
9/2019 QR-0.34-3.03Negative
12/2019 FY-1.0120.47Positive
12/2020 FY-1.2912.84Positive
Next Report Date8th Aug 2019
Estimated EPS Next Report-0.33
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume1 430 404
Shares Outstanding (in ths.)134 259
Trades Count3 217
Dollar Volume4 109 197
Avg. Volume1 317 100
Avg. Weekly Volume986 980
Avg. Monthly Volume748 195
Avg. Quarterly Volume884 392
Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (100.00 %)
3 (100.00 %)
2 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Agenus Inc.

Agenus Inc is an American biotechnology company. Its main target is immuno-oncology treatments. The company's portfolio consists of therapeutic antibodies and vaccines to treat immuno-oncology illnesses: cancers, shingles, malaria, glioblastoma, and others. Agenus treatments aim, by combining multiple antibody platforms, to stimulate the immune system to recognize and fight cancer cells. The company has been cooperating with companies like Incyte, Merck Sharp & Dohme, and Recepta Biopharma to achieve over a dozen antibody programs. Some of its products include Prophage, AutoSynVax, QS-21 Stimulon, and others.

CEO: Garo H Armen

Teplephone: +1 781 674-4400

Address: 3 Forbes Road, Lexington 02421-7305, MA, USA

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

54%46%

Bearish Bullish

72%28%

Bearish Bullish

44%56%

News